Pandemic Preparedness and Response in the post-COVID-19 era: Governance and PHSMs
,
 
,
 
Yi Cai 3
,
 
,
 
 
 
More details
Hide details
1
China CDC, Division of Infectious Diseases, China
 
2
Evidence-Based Vaccine Policy Research Office, Chinese Center for Disease Control and Prevention, China
 
3
School of Public Health, Wuhan University, China
 
4
Chinese Preventive Medicine Association;Asia-Pacific Regional Liaison Office,WFPHA; China Association for Science and Technology UN Consultative Committee on Life Science and Human Health (CCLH), China
 
5
Chinese Preventive Medicine Association; Disease Control and Prevention Institute of Jinan University; China Association for Science and Technology UN Consultative Committee on Life Science and Human Health (CCLH);WFPHA, China
 
 
Publication date: 2023-04-26
 
 
Popul. Med. 2023;5(Supplement):A549
 
ABSTRACT
In this workshop we will review the experiences and lessons learnt in the fight against COVID-19 in China for the purpose of better preparing for and responding to future pandemics, from the following perspectives: Taking a whole-of-government and a whole-of-society approach for the governance of COVID-19 pandemic is a key of success in the early phase of rapid containment. Immediately after the outbreak is reported, the Chinese government established a multi-sectoral joint response mechanism, consisting of 32 ministries, under the overall leadership of State Council. The national office for joint response mechanism oversees the epidemic situation and response actions, and over 4 million of community workers from 600,000 neighborhood committees in urban/rural areas were all mobilized for the implementation of public health and social measures (PHSMs) and the provision of logistic services during lockdown. Those approaches above have served as the fundamental basis for the successful elimination of COVID-19 outbreaks for a long period in China. The technical tools including massive testing, contact tracing using digital tools, and lockdown are key prerequisites for ‘Zero-COVID’ policy in China. Massive testing is necessary to rapidly screen the infected persons and put them under isolation so as to prevent further transmission. China has established sufficient PCR testing capacity. Digital tools and apps using big data technique are the enabler for timely epidemiological investigation and contact tracing to identify potential sources of infection and close contacts for quarantine, which attributed to the close collaboration between the public health sector, information technology sector, and the public security sector. Strict lockdown of high-risk areas is a useful tool to ensure the cut-off of the transmission at community level, while the basic services and logistic support are challenging and needs to be well arranged. The status and challenges of mass vaccination program in China. China was the first country to launch the COVID-19 vaccination campaign and has made positive progress in the fight against the COVID-19, with a complete vaccination rate of over 90% for the entire population. Details of COVID-19 mass vaccination campaign and practical challenges will be introduced in this workshop. Specific aims/objectives and component parts To provide an overview on Chinas collaborative governance mechanism and cross-sectoral cooperation approaches in response to COVID-19 pandemic; To demonstrate how technology plays a key role in mass testing, contact tracing, and lockdown through the experiences sharing; To share the practices how China pushed forward with the mass vaccination program and implemented public health and social measures by engaging and integrating community resources. Key questions that the dialogue will address What is the structure and mechanism of the WGA collaborative governance in China? What is the key of success in the early phase of rapid containment? How the use of technology enables China’s dynamic Zero-COVID policy? What challenges have been encountered in the implementation and how have they been effectively addressed? What are the challenges of COVID-19 vaccination in China and how we address those challenges in the preparedness for next pandemic?
ISSN:2654-1459
Journals System - logo
Scroll to top